A gradual decrease in the prevalence of NAFLD was noted in both genders along with the increased quartile of PRL (Q1, 37.0%; Q2, 25.9%; Q3, 25.9%; Q4, 13.2%; P = 0.046 in males; Q1, 25.7%; Q2, 11.4%; Q3, 8.6%; Q4, 2.9%; P = 0.025 in females) (Fig. 2). Here, PRL is linked to metabolic dysfunction-associated steatotic liver disease.